Publications Julia Hess
Sass, S. ; Pitea, A. ; Unger, K. ; Hess J. ; Müller, N.S. ; Theis, F.J.
MicroRNA-target network inference and local network enrichment analysis identify two microRNA clusters with distinct functions in head and neck squamous cell carcinoma.Hess J. ; Gimenez-Aznar, I. ; Michna, A. ; Kuger, S. ; Klein, D. ; Schoetz, U. ; Orth, M. ; Hieber, L. ; Braselmann, H. ; Schuettrumpf, L. ; Jendrossek, V. ; Belka, C. ; Zangen, V. ; Unger, K. ; Zitzelsberger, H. ; Lauber, K.
Signalling networks associated with FancA mediated radioresistance in cells of head and neck squamous cell carcinoma.Kuger, S. ; Hess J. ; Schötz, U. ; Gimenez-Aznar, I. ; Michna, A. ; Orth, M. ; Hieber, L. ; Braselmann, H. ; Klein, D. ; Schuettrumpf, L. ; Jendrossek, V. ; Belka, C. ; Zangen, V. ; Unger, K. ; Zitzelsberger, H. ; Lauber, K.
The influence of FancA overexpression on radioresistance in oral keratinocytes and HNSCC cells.Schoetz, U. ; Shnayien, S. ; Kinzel, L. ; Hess J. ; Zitzelsberger, H. ; Klein, D. ; Jendrossek, V. ; Belka, C. ; Unkel, S. ; Lauber, K.
Inherent radioresistance of head and neck squamous cell carcinoma cells: Principal component analysis identifies cellular senescence as a crucial driver.Schneider, L. ; Belka, C. ; Budach, W. ; Zitzelsberger, H. ; Unger, K. ; Hess J.
Identification and validation of predictive markers in head and neck squamous cell carcinomas.Braselmann, H. ; Michna, A. ; Hess J. ; Unger, K.
CFAssay: Statistical analysis of the colony formation assay.Gimenez-Aznar, I. ; Michna, A. ; Ludwig, H. ; Braselmann, H. ; Klein, D. ; Ohrt, M. ; Schoetz, U. ; Kuger, S. ; Schneider, L. ; Schuettrumpf, L. ; Jendrossek, V. ; Belka, C. ; Zangen, V. ; Unger, K. ; Zitzelsberger, H. ; Lauber, K. ; Hess J.
Fanconi anemia, complementation group A (FancA) overexpression confers radioresistance to oral keratinocytes.Summerer, I. ; Hess J. ; Pitea, A. ; Unger, K. ; Hieber, L. ; Selmansberger, M. ; Lauber, K. ; Zitzelsberger, H.
Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.Selmansberger, M. ; Braselmann, H. ; Hess J. ; Bogdanova, T. ; Abend, M. ; Tronko, M. ; Brenner, A. ; Zitzelsberger, H. ; Unger, K.
Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort.Groß, C. ; Steiger, K. ; Sayyed, S. ; Heid, I. ; Feuchtinger, A. ; Walch, A.K. ; Hess J. ; Unger, K. ; Zitzelsberger, H. ; Settles, M. ; Schlitter, A.M. ; Dworniczak, J. ; Altomonte, J. ; Ebert, O. ; Schwaiger, M. ; Rummeny, E.J. ; Steingötter, A. ; Esposito, I. ; Braren, R.
Model matters: Differences in orthotopic rat hepatocellular carcinoma physiology determine therapy response to sorafenib.Selmansberger, M. ; Kaiser, J.C. ; Hess J. ; Güthlin, D. ; Likhtarov, I. ; Shpak, V. ; Tronko, M. ; Brenner, A. ; Abend, M. ; Blettner, M. ; Unger, K. ; Jacob, P. ; Zitzelsberger, H.
Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas.Summerer, I. ; Niyazi, M. ; Unger, K. ; Pitea, A. ; Zangen, V. ; Hess J. ; Atkinson, M.J. ; Belka, C. ; Mörtl, S. ; Zitzelsberger, H.
Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.Schuster, F.R. ; Stanglmaier, M. ; Woessmann, W. ; Winkler, B. ; Siepermann, M. ; Meisel, R. ; Schlegel, P.G. ; Hess J. ; Lindhofer, H.G. ; Borkhardt, A. ; Buhmann, R.
Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies.Selmansberger, M. ; Feuchtinger, A. ; Zurnadzhy, L. ; Michna, A. ; Kaiser, J.C. ; Abend, M. ; Brenner, A. ; Bogdanova, T. ; Walch, A.K. ; Unger, K. ; Zitzelsberger, H. ; Hess J.
CLIP2 as radiation biomarker in papillary thyroid carcinoma.